154 related articles for article (PubMed ID: 23856830)
21. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
[TBL] [Abstract][Full Text] [Related]
22. Amyloid imaging: liberal or conservative? Let the data decide.
Jagust WJ
Arch Neurol; 2011 Nov; 68(11):1377-8. PubMed ID: 21747005
[No Abstract] [Full Text] [Related]
23. Impact of molecular imaging on the diagnostic process in a memory clinic.
Ossenkoppele R; Prins ND; Pijnenburg YA; Lemstra AW; van der Flier WM; Adriaanse SF; Windhorst AD; Handels RL; Wolfs CA; Aalten P; Verhey FR; Verbeek MM; van Buchem MA; Hoekstra OS; Lammertsma AA; Scheltens P; van Berckel BN
Alzheimers Dement; 2013 Jul; 9(4):414-21. PubMed ID: 23164552
[TBL] [Abstract][Full Text] [Related]
24. Amyloid deposition after cerebral hypoperfusion: evidenced on [(18)F]AV-45 positron emission tomography.
Huang KL; Lin KJ; Ho MY; Chang YJ; Chang CH; Wey SP; Hsieh CJ; Yen TC; Hsiao IT; Lee TH
J Neurol Sci; 2012 Aug; 319(1-2):124-9. PubMed ID: 22572706
[TBL] [Abstract][Full Text] [Related]
25. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
26. Florbetapir-PET imaging and postmortem beta-amyloid pathology.
Carome M; Wolfe S
JAMA; 2011 May; 305(18):1857; author reply 1857-8. PubMed ID: 21558513
[No Abstract] [Full Text] [Related]
27. GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.
Yao CH; Lin KJ; Weng CC; Hsiao IT; Ting YS; Yen TC; Jan TR; Skovronsky D; Kung MP; Wey SP
Appl Radiat Isot; 2010 Dec; 68(12):2293-7. PubMed ID: 20638295
[TBL] [Abstract][Full Text] [Related]
28. Imaging beta-amyloid burden in aging and dementia.
Linazasoro G
Neurology; 2008 Apr; 70(18):1649; author reply 1650. PubMed ID: 18443321
[No Abstract] [Full Text] [Related]
29. Association between clinical measures and florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia.
Witte MM; Trzepacz P; Case M; Yu P; Hochstetler H; Quinlivan M; Sundell K; Henley D
J Neuropsychiatry Clin Neurosci; 2014; 26(3):214-20. PubMed ID: 24618911
[TBL] [Abstract][Full Text] [Related]
30. Molecular imaging of dementia.
Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
[TBL] [Abstract][Full Text] [Related]
31. Amyloid imaging with PET in early Alzheimer disease diagnosis.
Rowe CC; Villemagne VL
Med Clin North Am; 2013 May; 97(3):377-98. PubMed ID: 23642577
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography imaging in dementia.
Herholz K; Carter SF; Jones M
Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
[TBL] [Abstract][Full Text] [Related]
33. PET imaging of brain amyloid in dementia: a review.
Quigley H; Colloby SJ; O'Brien JT
Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
[TBL] [Abstract][Full Text] [Related]
34. MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.
Saint-Aubert L; Payoux P; Hannequin D; Barbeau EJ; Campion D; Delisle MB; Tafani M; Viallard G; Péran P; Puel M; Chollet F; Demonet JF; Pariente J
Alzheimer Dis Assoc Disord; 2013; 27(1):91-4. PubMed ID: 22517194
[TBL] [Abstract][Full Text] [Related]
35. [Neurovisualization in the differential diagnosis of dementia].
Vlasenko AG; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):86-90. PubMed ID: 22983255
[No Abstract] [Full Text] [Related]
36. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
Grundman M; Pontecorvo MJ; Salloway SP; Doraiswamy PM; Fleisher AS; Sadowsky CH; Nair AK; Siderowf A; Lu M; Arora AK; Agbulos A; Flitter ML; Krautkramer MJ; Sarsour K; Skovronsky DM; Mintun MA;
Alzheimer Dis Assoc Disord; 2013; 27(1):4-15. PubMed ID: 23203162
[TBL] [Abstract][Full Text] [Related]
37. Novel imaging techniques using
Shouman K; Broski SM; Muchtar E; Pendleton CA; Johnson GB; Tracy J; Engelstad JK; Spinner RJ; Dyck PJB
Muscle Nerve; 2021 Jan; 63(1):104-108. PubMed ID: 33094511
[TBL] [Abstract][Full Text] [Related]
38. Association of Surgical Hospitalization with Brain Amyloid Deposition: The Atherosclerosis Risk in Communities-Positron Emission Tomography (ARIC-PET) Study.
Walker KA; Gottesman RF; Coresh J; Sharrett AR; Knopman DS; Mosley TH; Alonso A; Zhou Y; Wong DF; Brown CH
Anesthesiology; 2020 Jun; 132(6):1407-1418. PubMed ID: 32412719
[TBL] [Abstract][Full Text] [Related]
39. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S
J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
Villemagne VL; Okamura N; Pejoska S; Drago J; Mulligan RS; Chételat G; O'Keefe G; Jones G; Kung HF; Pontecorvo M; Masters CL; Skovronsky DM; Rowe CC
Neurodegener Dis; 2012; 10(1-4):161-5. PubMed ID: 22261520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
